Abstract
In medicine, the issue of the use of effective antibacterial substances against drug-resistant microorganisms remains relevant. Most publications on microcins show undoubted prospects for the further development of these pharmacological agents of bacterial origin with multidirectional action (antibacterial, antiviral, antitumor, etc.). One of the features of microcins is their specific inhibitory activity against gram-negative microorganisms (Escherichia, Proteus, Salmonella, Pseudomonas, etc.). This review aimed to briefly summarize current information about one of the groups of microcins (class II) to assess their possible use in practical medicine and scientific research. The review uses sources from the Russian Science Citation Index, Web of Science, Scopus, and PubMed databases.
Subject
Building and Construction
Reference47 articles.
1. Escherichia coli ST131: a multidrug-resistant clone primed for global domination
2. Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages
3. World Health Organization [Internet]. Lack of new antibiotics threatens global efforts to contain drug-resistant infections. World Health Organization News Release. 2020 [cited 2023 Apr 20]. Available from: https://www.who.int/news-room/detail/17-01-2020-lack-of-new-antibiotics-threatens-global-efforts-to-contain-drug-resistant-infections.
4. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature
5. Put a Bow on It: Knotted Antibiotics Take Center Stage